A workshop of SERES in Chongqing. [Photo/liangjiang.gov.cn]

Over the first five months of this year, the emerging strategic sectors in Liangjiang New Area, Southwest China's Chongqing municipality, recorded 82.52 billion yuan ($11.64 billion) of total industrial output, up 3.4 percent year-on-year.

Biomedicine and new energy vehicles (NEVs) stand out among these sectors.

An antineoplastic new medicine product developed by YaoPharma Co, a local biomedicine company, has been used in clinical tests. “After the produce enters the market, it is set to provide a better treatment choice to liver cancer patients and lift the financial burden on them,” said Liu Qiang, president of YaoPharma.

Liangjiang is now striving to build its life science and technology city and speed up forming three representative industrial clusters in medical equipment, biological products, and chemical agents.

Led by Changan, SERES, and other automakers in Chongqing, regions directly under the administration of the new area reported 63.34 billion yuan of automobile output, including 13.15 billion of NEV output, a surge of 112.8 percent.

Last year, Liangjiang formalized an action plan (2022-25) to advance the high-quality development of strategic emerging industries, which stated that by 2025, the industries' added value would account for 25 percent of the new area's GDP.

To achieve this goal, Liangjiang lays out NEV and intelligent connected vehicles, equipment manufacturing, new materials, and aerospace and aviation information businesses in Longsheng, New City.